Cost‐effectiveness of sofosbuvir‐based triple therapy for untreated patients with genotype 1 chronic hepatitis C

Salvatore Petta, Giuseppe Cabibbo, Marco Enea, Fabio Salvatore Macaluso, Antonella Plaia, Raffaele Bruno, Antonio Gasbarrini, Antonio Craxì, Calogero Cammà, WEF Study Group – 13 January 2014 – We assessed the cost‐effectiveness of sofosbuvir (SOF)‐based triple therapy (TT) compared with boceprevir (BOC)‐ and telaprevir (TVR)‐based TT in untreated genotype 1 (G1) chronic hepatitis C (CHC) patients discriminated according to IL28B genotype, severity of liver fibrosis, and G1 subtype. The available published literature provided the data source.

Cost‐effectiveness of sofosbuvir‐based triple therapy for untreated patients with genotype 1 chronic hepatitis C

Salvatore Petta, Giuseppe Cabibbo, Marco Enea, Fabio Salvatore Macaluso, Antonella Plaia, Raffaele Bruno, Antonio Gasbarrini, Antonio Craxì, Calogero Cammà, WEF Study Group – 13 January 2014 – We assessed the cost‐effectiveness of sofosbuvir (SOF)‐based triple therapy (TT) compared with boceprevir (BOC)‐ and telaprevir (TVR)‐based TT in untreated genotype 1 (G1) chronic hepatitis C (CHC) patients discriminated according to IL28B genotype, severity of liver fibrosis, and G1 subtype. The available published literature provided the data source.

Single‐center experience and long‐term outcomes of duct‐to‐duct biliary reconstruction in infantile living donor liver transplantation

Hidekazu Yamamoto, Shintaro Hayashida, Katsuhiro Asonuma, Masaki Honda, Hiroko Suda, Takahiro Murokawa, Yuki Ohya, Kwang‐Jong Lee, Takayuki Takeichi, Yukihiro Inomata – 10 January 2014 – The indications for duct‐to‐duct (DD) biliary reconstruction in living donor liver transplantation (LDLT) for small children are still controversial. In this study, the feasibility of DD biliary reconstruction versus Roux‐en‐Y (RY) biliary reconstruction was investigated in terms of long‐term outcomes.

Ethnic disparities and liver transplantation rates in hepatocellular carcinoma patients in the recent era: Results from the surveillance, epidemiology, and end results registry

Robert J. Wong, Pardha Devaki, Long Nguyen, Ramsey Cheung, Mindie H. Nguyen – 10 January 2014 – Hepatocellular carcinoma (HCC) is a leading cause of morbidity and mortality. After the implementation of the Model for End‐Stage Liver Disease system, rates of liver transplantation (LT) for HCC patients increased. However, it is not clear whether this trend has continued into recent times. Using the Surveillance, Epidemiology, and End Results registry (1998‐2010), we retrospectively analyzed trends for LT among HCC patients in 3 time periods: 1998‐2003, 2004‐2008, and 2009‐2010.

GATA4 loss in the septum transversum mesenchyme promotes liver fibrosis in mice

Irene Delgado, Manuel Carrasco, Elena Cano, Rita Carmona, Rocío García‐Carbonero, Luis M. Marín‐Gómez, Bernat Soria, Francisco Martín, David A. Cano, Ramón Muñoz‐Chápuli, Anabel Rojas – 10 January 2014 – The zinc finger transcription factor GATA4 controls specification and differentiation of multiple cell types during embryonic development. In mouse embryonic liver, Gata4 is expressed in the endodermal hepatic bud and in the adjacent mesenchyme of the septum transversum. Previous studies have shown that Gata4 inactivation impairs liver formation.

Subscribe to